Articles by Riley Griffin | Fortune

Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Leadership
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
By
James Paton,
Riley Griffin,
and others
March 24, 2021
Health
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines
By
Riley Griffin
and
Bloomberg
February 10, 2021
Health
Johnson & Johnson asks FDA for emergency authorization of its single-dose COVID vaccine
By
Riley Griffin
and
Bloomberg
February 5, 2021
Health
Merck ends development of two COVID-19 vaccines after weak trial results
By
Bloomberg
and
Riley Griffin
January 25, 2021
Health
J&J says efficacy of one-shot COVID-19 vaccine could beat expectations
By
Riley Griffin
and
Bloomberg
January 14, 2021
Health
Pfizer to supply U.S. with 100 million more vaccine doses
By
John Lauerman,
Riley Griffin,
and others
December 23, 2020
Health
U.S. plan to vaccinate most Americans by summer depends on AstraZeneca and J&J
By
Riley Griffin
and
Bloomberg
December 9, 2020
Health
Eli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By
Riley Griffin
and
Bloomberg
November 10, 2020
International
Germany funded the development of Pfizer’s COVID vaccine—not U.S.’s Operation Warp Speed
By
Riley Griffin,
Drew Armstrong,
and others
November 10, 2020
Health
Pfizer and BioNTech take the lead after study shows their vaccine prevents 90% of infections
By
Robert Langreth,
Naomi Kresge,
and others
November 9, 2020
International
Some scientists downplay significance of AstraZeneca’s COVID-19 vaccine trial halt
By
Michelle Fay Cortez,
Riley Griffin,
and others
September 9, 2020
Health
Anthony Fauci says coronavirus vaccine immunity is likely to be ‘finite’
By
Riley Griffin
and
Bloomberg
July 7, 2020
Health
Dr. Fauci’s worst nightmare? We’re living it
By
John Lauerman,
Riley Griffin,
and others
June 10, 2020
International
France’s Sanofi to sell stake in high-flying Regeneron to fund new drugs discoveries
By
James Paton,
Riley Griffin,
and others
May 26, 2020
Health
‘Pharma bro’ Martin Shkreli sued for alleged violation of antitrust law
By
Erik Larson,
Riley Griffin,
and others
January 27, 2020

1 - 15 of 18 results

1 - 15 of 18 results

© 2020 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Personal Information | Ad Choices
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html.
S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.